MedPath

ENYO PHARMA

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Study Evaluating Safety, Tolerability and Pharmacokinetics of EYP001a in Healthy Male Subjects

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Placebo
First Posted Date
2017-04-12
Last Posted Date
2017-04-13
Lead Sponsor
Enyo Pharma
Target Recruit Count
80
Registration Number
NCT03110276
© Copyright 2025. All Rights Reserved by MedPath